Flaskworks Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$4.3M
Flaskworks General Information
Description
Developor of life-saving immunotherapeutics intended for cancer and other diseases. The company's technology manufactures dendritic cells and develops modular, closed, and disposable systems that address the bottlenecks of therapies, thereby enabling physicians to treat patients successfully and more effectively.
Contact Information
Corporate Office
- 38 Wareham Street
- 3rd Floor
- Boston, MA 02118
- United States
Flaskworks Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 28-Aug-2020 | $4.3M | 00000 | 00.00 | Completed | Startup |
2. Angel (individual) | 29-Oct-2018 | 00000 | 00000 | Completed | Startup | |
1. Grant | 01-Jan-2018 | $225K | Completed | Startup |
Flaskworks Comparisons
Industry
Financing
Details
Flaskworks Competitors (21)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
CytImmune Sciences | Private Equity-Backed | Rockville, MD | 0 | 000.00 | 000000000000 | 000.00 |
Gadeta | Formerly VC-backed | Utrecht, Netherlands | 00 | 00.000 | 000000&0 | 00.000 |
NexImmune | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
Centrose | Venture Capital-Backed | Middleton, WI | 00 | 000.00 | 0000000000 0 | 000.00 |
Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | 00 | 00000 | 000000000 | 00000 |
Flaskworks Patents
Flaskworks Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3158509-A1 | Systems and methods for cell culturing | Pending | 21-Oct-2019 | 000000000 | |
AU-2020369940-A1 | Systems and methods for cell culturing | Pending | 21-Oct-2019 | 000000000 | |
US-20210115374-A1 | Systems and methods for cell culturing | Active | 21-Oct-2019 | 000000000 | |
US-20210115372-A1 | Systems and methods for cell culturing | Active | 21-Oct-2019 | 000000000 | |
US-20210115375-A1 | Systems and methods for cell culturing | Active | 21-Oct-2019 | C12M23/02 |
Flaskworks Signals
Flaskworks Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
National Science Foundation | Government | 000 0000 | 000000 0 |
Flaskworks FAQs
-
When was Flaskworks founded?
Flaskworks was founded in 2016.
-
Who is the founder of Flaskworks?
Shashi Murthy Ph.D is the founder of Flaskworks.
-
Where is Flaskworks headquartered?
Flaskworks is headquartered in Boston, MA.
-
What is the size of Flaskworks?
Flaskworks has 4 total employees.
-
What industry is Flaskworks in?
Flaskworks’s primary industry is Other Devices and Supplies.
-
Is Flaskworks a private or public company?
Flaskworks is a Private company.
-
What is the current valuation of Flaskworks?
The current valuation of Flaskworks is 00.00.
-
What is Flaskworks’s current revenue?
The current revenue for Flaskworks is 000000.
-
How much funding has Flaskworks raised over time?
Flaskworks has raised $750K.
-
Who are Flaskworks’s investors?
National Science Foundation has invested in Flaskworks.
-
Who are Flaskworks’s competitors?
CytImmune Sciences, Gadeta, NexImmune, Centrose, and Carisma Therapeutics are some of the 21 competitors of Flaskworks.
-
When was Flaskworks acquired?
Flaskworks was acquired on 28-Aug-2020.
-
Who acquired Flaskworks?
Flaskworks was acquired by Northwest Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »